A similar explanation has been proposed by Holmes et al for their finding that variation in dopamine receptor DRD3 (a candidate small effect gene of schizophrenia) is associated with development of delusions in Alzheimer Disease patients [27]. This evidence concerns the gene DRD3 and early-onset autosomal dominant Alzheimer disease.